Historic Victory for Prostate Cancer: Congress Adds $10 Million for Research Program
We did it! In a historic victory for prostate cancer research, the Prostate Cancer Research Program (PCRP) has received its first increase in funding in over a decade and is now funded at $90M!
We could not have achieved this victory without the dedicated advocates on our team. Thanks to your hard work, we are one step closer to much-needed research that will improve the diagnosis and treatment of prostate cancer and one day end suffering from the disease once and for all.
“The ZERO Prostate Cancer Run/Walk rallies communities and gives participants a voice in the fight to end prostate cancer.” – Jamie Bearse
This year our Run/Walk series will visit more than 40 cities across the country to promote awareness for prostate cancer and encourage men to be informed about their risk. Participants at each event will receive tech shirts, free food and prizes, and the opportunity to connect with others who are impacted by prostate cancer.
“It wasn’t until I was diagnosed with prostate cancer and got involved in the ZERO Run/Walk that I realized how prevalent the disease is. I was surprised by how many peole I knew were touched by it, or had lost a man to it, and just hadn’t openly discussed it before.” – Scott Moore, prostate cancer survivor and Run/Walk participant
In 2017, one in eight men will be diagnosed with prostate cancer in his lifetime. Next month we’re celebrating Men’s Health Month and Father’s Day with 30 Days for Dad – an opportunity to honor the men and fathers who are prostate cancer patients and survivors.
Sanguine Biosciences is looking for men from 18 – 73 years of age who have been diagnosed with localized prostate cancer to participate in a research study. Participation in this at-home study is voluntary; a member of their mobile health staff will meet you in the comfort of your home to perform the draw and thank you with $50 compensation for your time.
ZERO’s Statement on the House Passage of the American Health Care Act
While we celebrate a victory for prostate cancer research, we turn to the House of Representatives’ passage of the American Health Care Act (AHCA) with great concern not only for prostate cancer patients, but all patients with preexisting conditions.
Two years ago we started our Community Awareness Toolkit program to help advocates across the country spread knowledge about prostate cancer at community health events. We’re still going strong, with 30 Toolkits sent out so far this year!
Society of Nuclear Medicine and Molecular Imaging Survey
Check out this survey for patients who have had nuclear medicine imaging or therapy procedures and their caregivers. Hosted by our partner SNMMI, the results will help SNMMI members better understand current practice and future needs regarding patient care.
Get comprehensive patient support from ZERO360, no matter where you are in your prostate cancer journey.